Patents by Inventor Benjamin L. Laskin

Benjamin L. Laskin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab
    Patent number: 10815296
    Abstract: Disclosed are drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA, also called TA-TMA) in a subject that has undergone an HSCT. Also disclosed are methods of using drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA) in a subject that has undergone an HSCT.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: October 27, 2020
    Assignee: Children's Hospital Medical Center
    Inventors: Sonata Jodele, Benjamin L. Laskin
  • COMPOSITIONS AND METHODS FOR TREATMENT OF HSCT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
    Publication number: 20160194386
    Abstract: Disclosed are drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA, also called TA-TMA) in a subject that has undergone an HSCT. Also disclosed are methods of using drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA) in a subject that has undergone an HSCT.
    Type: Application
    Filed: September 16, 2014
    Publication date: July 7, 2016
    Inventors: Sonata Jodele, Benjamin L. Laskin